Delivery Order SPE2D020D0005-SPE2D324F8252

Award Date 4/15/24
Potential Completion Date 4/18/24
Potential Value $1.3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Congers, NY 10920, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract, valued at $1,184.50, is a delivery order for the supply of 4,564,381,636 units of ondansetron ODT (orally disintegrating tablet) 4 mg, packaged in 30s. The contract is a firm fixed price agreement and has an ultimate completion date of April 29, 2024. Chartwell RX LLC is the prime contractor for this award,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $3,354.27 delivery order is for the supply of 4566683111 - Ondansetron ODT 8 mg Tablet in 30-count packages. The contract is a Firm Fixed Price Indefinite Delivery Vehicle (IDV) that allows Chartwell RX to manufacture and distribute a broad range of medications, including oral antibiotics, antivirals,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order contract (SPE2D020D0005|SPE2D324F182T) to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The $2,842.80 Firm Fixed Price contract is for the delivery of 4565371887 - Ondansetron ODT 4 mg Tablets, 30-count. This delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) between Chartwell RX and DLA Troop Support Medical, valued at over $7 million and running...
The federal contract award to Chartwell RX LLC, a for-profit pharmaceutical distributor, is for the delivery of Ondansetron ODT 8 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,354.27 firm fixed price delivery order is part of a larger $7 million+ single-award indefinite delivery vehicle (IDV) contract that Chartwell holds with the DLA for manufacturing and global distribution of drugs and biologics. This contract allows the DLA to issue task orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $2,842.80 firm-fixed-price delivery order is for the supply of ondansetron orally disintegrating tablets, a medication used to prevent nausea and vomiting. The award is part of a larger single-award Indefinite Delivery Contract (IDC) valued at over $7 million, which allows Chartwell RX to manufacture and...
This firm fixed price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York. The $3,946.20 contract is for the delivery of Ondansetron ODT 8 mg tablets in 30-count packages, with a completion date of February 6, 2024. Chartwell RX is an experienced federal contractor, holding multiple indefinite delivery vehicle contracts with the Department of Veterans Affairs and Defense Logistics...
The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order to Chartwell RX LLC, a for-profit organization, for the supply of ondansetron orally disintegrating tablets. The $1,302.95 order is part of Chartwell RX's broader contract vehicles with the Defense Logistics Agency and the Department of Veterans Affairs to provide pharmaceutical products to support military and veteran healthcare services. No set-asides were used for this specific delivery order, which...
This federal contract award to Chartwell RX LLC, a pharmaceutical company based in Congers, New York, is a delivery order (SPE2D020D0005|SPE2D324F090W) valued at $4,143.51. The contract is for the supply of 4565064518 - Ondansetron ODT 8 mg Tablet 30s, a medication used to treat nausea and vomiting. The contract is issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense that provides medical supplies and services to military personnel and other...
This is a $1,776.75 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The contract is for the supply of 4 mg ondansetron orally disintegrating tablets in 30-count packages. This delivery order is issued under Chartwell RX's existing Indefinite Delivery Contract (SPE2D020D0005) with DLA, which enables the company to manufacture and distribute a broad range of...
This contract award to Chartwell RX LLC, a for-profit pharmaceutical company based in Congers, New York, is for the delivery of ondansetron orally disintegrating tablets in 30-count packages. The $2,369.00 firm fixed-price delivery order was issued on November 8, 2024, with a completion date of November 14, 2024. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at over $7 million with the Defense Logistics Agency (DLA) Troop Support Medical, which allows...
  • SPE2D020D0005
    Indefinite Delivery Contract
  • SPE2D020D0005-SPE2D324F8252
    Delivery Order

The federal contract award SPE2D020D0005|SPE2D324F8252 was granted to Chartwell RX LLC, a pharmaceutical company based in Congers, New York. The $1,302.95 fixed-price delivery order contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical to provide 4,564,273,639 units of the medication ondansetron ODT 4 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at over $7 million and running through March 2030, which allows Chartwell RX to manufacture and distribute a range of medications to military treatment facilities worldwide. Chartwell RX has also secured other federal contracts, including a $139.7 million small business set-aside award for doxycycline and amoxicillin, as well as a Federal Supply Schedule contract with the Department of Veterans Affairs. The company's pharmaceutical expertise and ability to meet diverse government healthcare needs have contributed to its success as a prime contractor for the federal government.

Generated 7/15/24, 6:57 PM